Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2007 3
2008 9
2009 1
2010 1
2011 2
2012 5
2013 2
2014 1
2015 3
2017 1
2018 2
2019 7
2020 12
2021 5
2022 11
2023 11
2024 11
2025 11
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
CIC-DUX4 sarcomas.
Brahmi M, Vanacker H, Macagno N, Tirode F, Dufresne A. Brahmi M, et al. Among authors: dufresne a. Curr Opin Oncol. 2022 Jul 1;34(4):342-347. doi: 10.1097/CCO.0000000000000855. Epub 2022 Jun 22. Curr Opin Oncol. 2022. PMID: 35730520 Review.
Medical treatment of angiosarcomas.
Dufresne A, Dupont M, Brahmi M. Dufresne A, et al. Curr Opin Oncol. 2025 Jul 1;37(4):372-376. doi: 10.1097/CCO.0000000000001147. Epub 2025 Apr 23. Curr Opin Oncol. 2025. PMID: 40422812 Review.
Treatment of radiation-associated angiosarcoma.
Dufresne A, Meeus P, Sunyach MP. Dufresne A, et al. Curr Opin Oncol. 2023 Jul 1;35(4):296-300. doi: 10.1097/CCO.0000000000000958. Epub 2023 May 12. Curr Opin Oncol. 2023. PMID: 37222197 Review.
Sinonasal Sarcomas Management: An International Consensus Statement.
Vinciguerra A, Caspani F, Valentini M, Camarda AM, Provenzano S, Wang EW, Meço C, Ferrari M, Surda P, Harrabi S, Campos FAB, Broto JM, Guadagnolo BA, Navarria P, Hosni A, Hindi N, Italiano A, Trifiletti DM, Kasper B, Verillaud B, Schreiber A, Castelnuovo P, Nicolai P, Dallan I, Chacon M, Su SY, Thariat J, Valverde C, Lechner M, Blay JY, Fiore MR, Eloy JA, Brahmi M, Palmer JN, Oliden VC, Greto D, Lugowska I, Tos APD, van Zele T, Psaltis AJ, Casali PG, Dufresne A, Sangalli C, Georgalas C, Orlandi E, Wormald PJ, Herman P, Carrau R, Hanna EY, Licitra L, Turri-Zanoni M, Battaglia P. Vinciguerra A, et al. Among authors: dufresne a. Int Forum Allergy Rhinol. 2026 Jan;16(1):55-69. doi: 10.1002/alr.70038. Epub 2025 Sep 30. Int Forum Allergy Rhinol. 2026. PMID: 41025537 Free PMC article.
Cellular therapies in sarcoma and other solid tumors.
Dupont M, de Bernardi A, Vanacker H, Dufresne A, Brahmi M, Blay JY. Dupont M, et al. Among authors: dufresne a. Curr Opin Oncol. 2025 Jul 1;37(4):365-371. doi: 10.1097/CCO.0000000000001152. Epub 2025 May 5. Curr Opin Oncol. 2025. PMID: 40423031 Review.
Immunotherapy in Sarcoma: Where Do Things Stand?
Moreno Tellez C, Leyfman Y, D'Angelo SP, Wilky BA, Dufresne A. Moreno Tellez C, et al. Among authors: dufresne a. Surg Oncol Clin N Am. 2022 Jul;31(3):381-397. doi: 10.1016/j.soc.2022.03.004. Surg Oncol Clin N Am. 2022. PMID: 35715140 Review.
The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity.
Frezza AM, Leonard H, Aggerholm-Pedersen N, Badalamenti G, Baili P, Baldi GG, Bauer S, Bazzurri S, Benzonelli I, Bertuzzi A, Blay JY, Bianchi G, Bonfarnuzzo S, Bouvier C, Boye K, Martin Broto J, Brunello A, Campanacci D, Casali PG, Cicala C, Crotti E, D'Ambrosio L, Dei Tos AP, Dieckmann N, Dufresne A, Elston S, Ferraresi V, Gabellini S, Giani C, Giannusa V, Gil Sanjines M, Grassani T, Gronchi A, Lasalvia P, Lindskog S, Hindi N, Ingrosso M, Ivanescu A, Jones R, Lugowska I, Ketzer J, Mariuk-Jarema A, Mazzocca A, Monteleone L, Morosi C, Napolitano A, Nardozza F, Neri E, Nilsson M, Papakonstantinou A, Pasquali S, Sbaraglia M, Scolari F, Szkandera J, Valverde C, Vincenzi B, Vizzaccaro S, Zuccheri F, Stacchiotti S, Trama A. Frezza AM, et al. Among authors: dufresne a. PLoS One. 2024 Aug 12;19(8):e0308387. doi: 10.1371/journal.pone.0308387. eCollection 2024. PLoS One. 2024. PMID: 39133752 Free PMC article.
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.
Stacchiotti S, Pantziarka P, Leonard H, Voltz C, Abatedaga L, Bouche G, Bouygues C, Bovee JVMG, Van der Graaf WTA, Rojas T, D'Ambrosio L, Donoghue M, Enzmann H, Feeney G, Foggi P, Frezza AM, Herold R, Jones RL, Kasper B, Roes K, Marreaud S, Miceli R, Robinson D, Sommer J, Tap WD, Tydings C, Trama A, Houdt WV, van Oortmerssen G, Wagner AJ, Widemann B, Gelderblom H, Gronchi A, Napolitano A, Dufresne A, Fumagalli ER, Baldi G, Marquina G, Koseła-Paterczyk H, Martin Javier JB, Junker N, Rutkowski P, Oyen WJG, Lacombe D, Pignatti F, Demolis P. Stacchiotti S, et al. Among authors: dufresne a. Cancer Treat Rev. 2025 Nov;140:103003. doi: 10.1016/j.ctrv.2025.103003. Epub 2025 Aug 6. Cancer Treat Rev. 2025. PMID: 40789252 Review.
94 results